Key result
Proton-pump inhibitor use in hypertensive patients was independently associated with blood pressure control (OR 2.70) and lower systolic (135 vs 139 mmHg; p=0.02) blood pressure.
Why the study?
Does regular use of Proton-Pump Inhibitors reduce 24-hour ambulatory blood pressure in hypertensive patients?
Observational (n=462)
Does regular use of Proton-Pump Inhibitors reduce 24-hour ambulatory blood pressure in hypertensive patients?
Concomitant PPI therapy in hypertensive patients is associated with a statistically significant but clinically irrelevant reduction in 24-hour ambulatory blood pressure.
Objective: To evaluate the potential impact of inhibitors of proton-pump in blood-pressure. .Methods: In a 24-hour-ambulatory-blood-pressure-monitoring (AMBP)-database we analyzed records of 462-hypertensive-patients according Proton-Pump Inhibitors (PPI). 150(33%)-patients were regularly users of PPI, and 312(67%) nonusers of PPI. Ambulatory-blood-pressure was measured non-invasively for 24--hours by the Spacelab-devices programmed-to-measure every 20-minutes during-daytime and every 60-minutes during-nighttime.Results: Systolic-blood-pressure(SBP) was lower in the Proton-Pump-Inhibitors (PPI)-group (13520.vs.13916mmHg, p=0,02) as well as diastolic-blood-pressure (DBP) (7610.vs.8310mmHg, p<0.001). Multivariate-analysis showed that use of beta-blocker(OR, 2.60) and PPI(OR, 2.70), were independently associated with blood-pressure-control.Conclusions: This study shows that concomitant PPI therapy in hypertensive-patients was associated with a small but statistically significant-reduction in 24-hours-BP, even after multivariate-adjustment. However, This statistical difference seems to lack clinical relevance.
No takes yet. Share an insight, caveat, or question.
Joya-Vázquez et al. (2014) conducted an observational in Hypertension (n=462). Proton-Pump Inhibitors (PPI) vs. Nonusers of PPI was evaluated on Blood pressure control (OR 2.70). Proton-pump inhibitor use in hypertensive patients was independently associated with blood pressure control (OR 2.70) and lower systolic (135 vs 139 mmHg; p=0.02) blood pressure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: